OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Clinical Endocrinology & Metabolism is 50. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Correction to “Recent Insights into Noncoding RNAs in Primary Ovarian Insufficiency: Focus on Mechanisms and Treatments”	686
Correction to: “Associations of Serum Vitamin B6 Status and Catabolism With All-Cause Mortality in Patients With T2DM”	435
Correction to: “Critical Approach to Hypothyroid Patients With Persistent Symptoms”	245
Response to Letter to the Editor From Jagannath and Mayilvaganan: “FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography”	208
Response to Letter to the Editor From de Zegher and Ibáñez: “Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis”	172
A Step Toward Disentangling the Complex Relationship Between Vitamin D and Kidney Function	133
Correction to: “Contralateral Suppression in Adrenal Venous Sampling Predicts Clinical and Biochemical Outcome in Primary Aldosteronism”	117
Response to Letter to the Editor From Sukor and Kamaruddin: “Higher Risk of Incident Hyperthyroidism in Patients With Atrial Fibrillation”	104
Anti-Androgen and Aromatase Inhibitor Do Not Enhance Height in Children With CAH	100
Iodineminho Study: Iodine Supplementation and Prevalence of Iodine Deficiency In Pregnant Women	94
Signs of Potential Androgen Excess Across the Lifespan in a US-based Digital Cohort Study	90
Insights on Improving Health Insurance Literacy in Diabetes	89
Elevated TSH Level, TgAb, and Prior Use of Ramucirumab or TKIs as Risk Factors for Thyroid Dysfunction in PD-L1 Blockade	87
Clinical and Molecular Genetic Characteristics of Patients with Hereditary Hypophosphatemia	87
Correction to: “Vitamin D Status, Vitamin D Receptor Polymorphisms, and Risk of Type 2 Diabetes: A Prospective Cohort Study”	83
Signs of a Glucose- and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes	81
Changes in Collagen Type I C-Telopeptide and Procollagen Type I N-Terminal Propeptide During the Menopause Transition	80
GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1	80
Response to Letter to the Editor From Hasebe and Su: “Adrenalectomy Reduces the Risk of Vertebral Fractures in Patients With Mild Autonomous Cortisol Secretion”	79
Serum 25-Hydroxyvitamin D is Associated With Bone Microarchitecture and Strength in a Multiracial Cohort of Young Adults	79
Further Data Against the Use of Cyproterone Acetate in Gender-Affirming Hormone Therapy Regimens	72
Correction to: “Triglyceride–Glucose Index and Risks of All-Cause and Cause-Specific Mortality in Young Adults”	71
Correction to: “Metabolic Profiles of Pregnancy With Polycystic Ovary Syndrome: Insights into Maternal-Fetal Metabolic Communication”	71
Correction to: “Determinants of Pancreatic Size and Fat Content in the UK Biobank: Influence of Race, Genetic Variants, and Risk Factors”	70
Glycemic, Cardiorenal, and Weight Implications on Noninsulin Pharmacotherapy for the Management of Type 2 Diabetes	69

Transitions in Metabolic Health Status and Obesity Over Time and Risk of Diabetes: The Dongfeng–Tongji Cohort Study	69
Characterizing 24-Hour Skeletal Muscle Gene Expression Alongside Metabolic and Endocrine Responses Under Diurnal Conditions	68
Stable Iodine Intake and Thyroid Screening Outcomes After the Fukushima Nuclear Disaster: An Observational Study	66
Correction to “Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study”	65
Time to Increase Awareness and Diagnosis of Steatotic Liver Disease in Adolescents	64
Association of Age at Menarche With Inflammation and Glucose Metabolism Biomarkers in US Adult Women: NHANES 1999-2018	62
Correction to: “Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline”	62
Approach to the Patient: Type 1 Diabetes Management With Exercise—Prepare, Perform, Stabilize, and Study	61
The Diagnostic Value of 18F-FDG PET/CT Scan in Characterizing Adrenal Tumors	60
Gender-Affirming Treatment and Employment Rate in 3812 Danish Transgender Persons and 38 120 Controls	60
Type 2 Diabetes Remission: Achieving Calorie Restriction and Weight Loss by Any Which Way?	60
Initial Evaluation of Radioiodine Therapy Using Imaging for Long-term Prognosis in Thyroid Cancer: A Retrospective Study	60
New Treatments for Acromegaly in Development	59
Hemoglobin Glycation Index: A Novel Risk Factor for Incident Chronic Kidney Disease in an Apparently Healthy Population	58
Suppression of Endogenous Insulin Secretion by Euglycemic Hyperinsulinemia	57
Tracking and Cumulative Lifetime Exposure to IGF-I in 6459 Healthy Individuals and in SGA Children Treated With GH	57
Turner's Syndrome, Glucagon-like Peptide 1, and Glucose-dependent Insulinotropic Polypeptide Agents: Silver Bullets?	57
Effect of Anamorelin, a Ghrelin Receptor Agonist, on Muscle and Bone in Adults With Osteosarcopenia	56
Association Between Urinary Phthalate Metabolites and Sarcopenia in US Adults From NHANES 2011-2018	56
Association of Thyroid Dysfunction in Individuals ≥ 65 Years of Age With Subclinical Cardiac Abnormalities	55
Association of Circulating Very Long-Chain Saturated Fatty Acids With Cardiovascular Mortality in NHANES 2003-2004, 2011-2012	55
Sex Steroids and Women’s Physical Performance in Midlife: Findings From the Menarche-To-PreMenopause Study	54
Mesenteric Visceral Lipectomy Improves Glucose Tolerance in Patients With Type 2 Diabetes: A Pilot Study	54
Ectopic Cervical Thymoma in a Patient Diagnosed With Graves Disease: A Systematic Literature Review	54
Growth Patterns of Children With Short Stature in Adulthood According to Auxological Status and Maturity at Birth	54
Circulating miRNAs Respond to Denosumab Treatment After 2 Years in Postmenopausal Women With Osteoporosis—the MiDeTe study	50